Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 19 | 2019 | 402 | 2.850 |
Why?
|
| Mammography | 12 | 2017 | 43 | 2.130 |
Why?
|
| Kidney Failure, Chronic | 18 | 2021 | 125 | 2.010 |
Why?
|
| Racism | 4 | 2022 | 29 | 1.830 |
Why?
|
| Early Detection of Cancer | 5 | 2018 | 102 | 1.700 |
Why?
|
| Healthcare Disparities | 7 | 2023 | 77 | 1.690 |
Why?
|
| Health Services Accessibility | 14 | 2021 | 105 | 1.650 |
Why?
|
| Registries | 17 | 2011 | 192 | 1.520 |
Why?
|
| Health Status Disparities | 5 | 2020 | 73 | 1.510 |
Why?
|
| Renal Replacement Therapy | 10 | 2011 | 18 | 1.500 |
Why?
|
| Kidney Transplantation | 9 | 2021 | 115 | 1.390 |
Why?
|
| Medically Uninsured | 2 | 2021 | 12 | 1.190 |
Why?
|
| Physicians | 2 | 2022 | 114 | 1.080 |
Why?
|
| Humans | 77 | 2023 | 25967 | 0.990 |
Why?
|
| Primary Health Care | 3 | 2021 | 78 | 0.880 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 105 | 0.860 |
Why?
|
| Middle Aged | 44 | 2021 | 8772 | 0.810 |
Why?
|
| Female | 57 | 2021 | 14734 | 0.800 |
Why?
|
| Health Facilities | 1 | 2023 | 26 | 0.790 |
Why?
|
| Health Equity | 1 | 2023 | 15 | 0.790 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 124 | 0.780 |
Why?
|
| Chicago | 23 | 2019 | 898 | 0.780 |
Why?
|
| Renal Dialysis | 11 | 2021 | 84 | 0.770 |
Why?
|
| Human Rights | 1 | 2022 | 3 | 0.760 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 136 | 0.730 |
Why?
|
| Referral and Consultation | 3 | 2021 | 84 | 0.730 |
Why?
|
| Health Personnel | 1 | 2022 | 87 | 0.710 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 36 | 0.710 |
Why?
|
| Adult | 37 | 2021 | 7662 | 0.710 |
Why?
|
| Socioeconomic Factors | 12 | 2020 | 294 | 0.710 |
Why?
|
| Community Health Services | 1 | 2021 | 32 | 0.700 |
Why?
|
| Dyslipidemias | 2 | 2018 | 16 | 0.700 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 50 | 0.670 |
Why?
|
| Cardiovascular Diseases | 4 | 2018 | 307 | 0.660 |
Why?
|
| Hospitalization | 2 | 2022 | 301 | 0.640 |
Why?
|
| Mass Screening | 10 | 2017 | 170 | 0.640 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 254 | 0.640 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 6 | 0.620 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 3 | 0.620 |
Why?
|
| Cholesterol, LDL | 2 | 2018 | 29 | 0.600 |
Why?
|
| Aged | 33 | 2021 | 8732 | 0.600 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 252 | 0.590 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 28 | 0.580 |
Why?
|
| Violence | 1 | 2018 | 34 | 0.580 |
Why?
|
| Survival Rate | 7 | 2011 | 333 | 0.570 |
Why?
|
| Mortality | 5 | 2018 | 87 | 0.530 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 40 | 0.500 |
Why?
|
| United Kingdom | 12 | 2011 | 46 | 0.480 |
Why?
|
| Residence Characteristics | 5 | 2019 | 205 | 0.480 |
Why?
|
| Health Policy | 2 | 2015 | 35 | 0.480 |
Why?
|
| Undocumented Immigrants | 1 | 2015 | 1 | 0.480 |
Why?
|
| Value of Life | 1 | 2015 | 1 | 0.470 |
Why?
|
| Insurance Coverage | 1 | 2015 | 10 | 0.470 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 20 | 0.460 |
Why?
|
| Male | 33 | 2021 | 14277 | 0.450 |
Why?
|
| Peritoneal Dialysis | 3 | 2011 | 26 | 0.440 |
Why?
|
| Young Adult | 13 | 2021 | 1941 | 0.430 |
Why?
|
| Hospitals | 4 | 2022 | 157 | 0.410 |
Why?
|
| Cause of Death | 4 | 2011 | 64 | 0.410 |
Why?
|
| Waiting Lists | 2 | 2010 | 18 | 0.400 |
Why?
|
| United States | 10 | 2021 | 1989 | 0.400 |
Why?
|
| Outpatient Clinics, Hospital | 4 | 2002 | 13 | 0.400 |
Why?
|
| Community Health Planning | 2 | 2009 | 18 | 0.390 |
Why?
|
| Tissue Donors | 2 | 2010 | 73 | 0.380 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 609 | 0.380 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 851 | 0.370 |
Why?
|
| Retrospective Studies | 12 | 2021 | 3358 | 0.370 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 785 | 0.370 |
Why?
|
| Hemoglobins | 4 | 2009 | 30 | 0.360 |
Why?
|
| Adolescent | 9 | 2021 | 2099 | 0.350 |
Why?
|
| National Health Programs | 2 | 2010 | 3 | 0.340 |
Why?
|
| Cesarean Section | 4 | 2014 | 29 | 0.340 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 13 | 0.330 |
Why?
|
| Risk Factors | 11 | 2018 | 2237 | 0.330 |
Why?
|
| Risk Assessment | 7 | 2018 | 603 | 0.330 |
Why?
|
| Community Participation | 1 | 2009 | 17 | 0.320 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 4641 | 0.310 |
Why?
|
| Incidence | 9 | 2019 | 729 | 0.300 |
Why?
|
| ErbB Receptors | 1 | 2009 | 54 | 0.300 |
Why?
|
| Breech Presentation | 1 | 2008 | 3 | 0.300 |
Why?
|
| Version, Fetal | 1 | 2008 | 3 | 0.300 |
Why?
|
| Medical Audit | 1 | 2008 | 5 | 0.300 |
Why?
|
| Pregnancy | 8 | 2020 | 327 | 0.290 |
Why?
|
| Smoking | 2 | 2005 | 180 | 0.270 |
Why?
|
| Poverty | 6 | 2010 | 92 | 0.270 |
Why?
|
| Hospitals, Public | 6 | 2002 | 27 | 0.270 |
Why?
|
| Diabetes Mellitus | 3 | 2005 | 121 | 0.270 |
Why?
|
| Annual Reports as Topic | 3 | 2010 | 3 | 0.250 |
Why?
|
| Guideline Adherence | 3 | 2018 | 57 | 0.250 |
Why?
|
| Intubation | 1 | 2005 | 6 | 0.240 |
Why?
|
| Heroin Dependence | 1 | 2005 | 9 | 0.240 |
Why?
|
| Public Health | 2 | 2017 | 64 | 0.240 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 13 | 0.240 |
Why?
|
| Extraction, Obstetrical | 2 | 1995 | 2 | 0.240 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 18 | 0.230 |
Why?
|
| Smoking Cessation | 1 | 2005 | 46 | 0.230 |
Why?
|
| Geographic Information Systems | 1 | 2004 | 4 | 0.230 |
Why?
|
| Time Factors | 6 | 2018 | 1391 | 0.220 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 8 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3399 | 0.220 |
Why?
|
| Age Factors | 6 | 2018 | 757 | 0.220 |
Why?
|
| Health Status Indicators | 1 | 2004 | 70 | 0.210 |
Why?
|
| New Zealand | 6 | 2019 | 11 | 0.210 |
Why?
|
| Cities | 3 | 2018 | 15 | 0.210 |
Why?
|
| Asthma | 1 | 2005 | 153 | 0.210 |
Why?
|
| Commerce | 1 | 2023 | 11 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 1994 | 33 | 0.200 |
Why?
|
| Patient Transfer | 2 | 1996 | 25 | 0.190 |
Why?
|
| Uncompensated Care | 1 | 2002 | 2 | 0.190 |
Why?
|
| Databases, Factual | 3 | 2019 | 337 | 0.190 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 12 | 0.190 |
Why?
|
| Morbidity | 2 | 2001 | 51 | 0.190 |
Why?
|
| Health Priorities | 1 | 2001 | 4 | 0.180 |
Why?
|
| Public Health Administration | 1 | 2001 | 9 | 0.180 |
Why?
|
| Patient Compliance | 3 | 2018 | 149 | 0.180 |
Why?
|
| Social Class | 3 | 2010 | 62 | 0.180 |
Why?
|
| Aftercare | 1 | 2021 | 22 | 0.180 |
Why?
|
| Health Surveys | 3 | 2007 | 87 | 0.170 |
Why?
|
| Research Design | 2 | 2020 | 183 | 0.170 |
Why?
|
| Dystocia | 1 | 2020 | 1 | 0.170 |
Why?
|
| Neoplasms | 2 | 2017 | 230 | 0.160 |
Why?
|
| England | 5 | 2011 | 15 | 0.160 |
Why?
|
| Income | 2 | 2005 | 77 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2011 | 75 | 0.160 |
Why?
|
| Cholesterol | 2 | 2018 | 59 | 0.160 |
Why?
|
| Sociology, Medical | 1 | 2019 | 2 | 0.160 |
Why?
|
| Prevalence | 6 | 2014 | 433 | 0.160 |
Why?
|
| Comorbidity | 3 | 2017 | 476 | 0.150 |
Why?
|
| Hospitals, Urban | 2 | 1998 | 34 | 0.150 |
Why?
|
| Quality of Health Care | 4 | 2020 | 97 | 0.150 |
Why?
|
| Mortality, Premature | 1 | 2018 | 5 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2009 | 258 | 0.150 |
Why?
|
| Illinois | 4 | 2015 | 235 | 0.150 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 16 | 0.150 |
Why?
|
| Global Health | 1 | 2018 | 34 | 0.150 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 19 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2019 | 545 | 0.140 |
Why?
|
| General Practice | 1 | 2018 | 2 | 0.140 |
Why?
|
| Biomarkers | 2 | 2018 | 544 | 0.140 |
Why?
|
| Germany | 1 | 2017 | 6 | 0.140 |
Why?
|
| Women's Health | 2 | 2017 | 173 | 0.140 |
Why?
|
| Wales | 4 | 2010 | 5 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2017 | 7 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2017 | 99 | 0.140 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 160 | 0.130 |
Why?
|
| Health Education | 3 | 1994 | 44 | 0.130 |
Why?
|
| False Negative Reactions | 1 | 2016 | 14 | 0.130 |
Why?
|
| Prognosis | 4 | 2012 | 784 | 0.130 |
Why?
|
| Quality Control | 1 | 2016 | 26 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 473 | 0.130 |
Why?
|
| Facility Regulation and Control | 1 | 1996 | 1 | 0.130 |
Why?
|
| Urban Health | 3 | 2004 | 22 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 31 | 0.130 |
Why?
|
| Observer Variation | 1 | 2016 | 97 | 0.130 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 360 | 0.130 |
Why?
|
| Epidemiologic Methods | 2 | 2015 | 18 | 0.130 |
Why?
|
| Urban Population | 5 | 2005 | 149 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 1996 | 32 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 30 | 0.120 |
Why?
|
| Patient Safety | 1 | 2016 | 36 | 0.120 |
Why?
|
| Civil Defense | 1 | 2015 | 4 | 0.120 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 7 | 0.120 |
Why?
|
| Financing, Government | 1 | 2015 | 8 | 0.120 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 8 | 0.120 |
Why?
|
| Hospitals, Maternity | 1 | 1995 | 3 | 0.120 |
Why?
|
| Stereotyping | 1 | 2015 | 17 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 311 | 0.110 |
Why?
|
| Cohort Studies | 6 | 2019 | 1806 | 0.110 |
Why?
|
| Schools, Medical | 1 | 2015 | 26 | 0.110 |
Why?
|
| Birth Weight | 1 | 2014 | 38 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2015 | 44 | 0.110 |
Why?
|
| Students, Medical | 1 | 2015 | 53 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 649 | 0.110 |
Why?
|
| HIV Seroprevalence | 1 | 1994 | 3 | 0.110 |
Why?
|
| Syphilis | 1 | 1994 | 2 | 0.110 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1994 | 12 | 0.110 |
Why?
|
| Community Health Nursing | 1 | 1994 | 6 | 0.110 |
Why?
|
| Postpartum Period | 1 | 1993 | 21 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 88 | 0.090 |
Why?
|
| Hemodialysis, Home | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tetanus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Disasters | 1 | 2011 | 2 | 0.090 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2011 | 13 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 13 | 0.090 |
Why?
|
| Europe | 4 | 2010 | 57 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 17 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 1757 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2010 | 82 | 0.080 |
Why?
|
| Patient Selection | 2 | 2011 | 190 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2009 | 1701 | 0.080 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2009 | 1 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2009 | 19 | 0.080 |
Why?
|
| Health Services Research | 3 | 2002 | 37 | 0.080 |
Why?
|
| Living Donors | 1 | 2009 | 17 | 0.080 |
Why?
|
| HIV Infections | 1 | 1994 | 434 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2009 | 268 | 0.070 |
Why?
|
| Counseling | 1 | 2008 | 40 | 0.070 |
Why?
|
| Logistic Models | 1 | 2009 | 391 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2002 | 124 | 0.070 |
Why?
|
| Mexico | 1 | 2007 | 15 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 466 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 57 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2006 | 39 | 0.060 |
Why?
|
| Parathyroid Hormone | 3 | 2010 | 23 | 0.060 |
Why?
|
| Unemployment | 1 | 2005 | 2 | 0.060 |
Why?
|
| Reoperation | 1 | 2009 | 888 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 175 | 0.060 |
Why?
|
| Infant | 2 | 2009 | 495 | 0.060 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 3 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 12 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 597 | 0.060 |
Why?
|
| Chest Pain | 1 | 2004 | 20 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 13 | 0.060 |
Why?
|
| Critical Care | 1 | 2005 | 113 | 0.060 |
Why?
|
| Attitude to Health | 3 | 2011 | 95 | 0.060 |
Why?
|
| Lung | 1 | 2004 | 157 | 0.050 |
Why?
|
| Educational Status | 1 | 2005 | 282 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2005 | 248 | 0.050 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 76 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 655 | 0.050 |
Why?
|
| Child | 2 | 2009 | 1217 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 8 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1483 | 0.050 |
Why?
|
| Poverty Areas | 1 | 2001 | 9 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2009 | 251 | 0.040 |
Why?
|
| Health Care Surveys | 2 | 1998 | 64 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 116 | 0.040 |
Why?
|
| Phosphates | 2 | 2010 | 18 | 0.040 |
Why?
|
| Axilla | 1 | 2019 | 14 | 0.040 |
Why?
|
| Traction | 1 | 2019 | 30 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2018 | 26 | 0.040 |
Why?
|
| Ontario | 1 | 2018 | 16 | 0.040 |
Why?
|
| North America | 1 | 2018 | 38 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1998 | 2 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 82 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 15 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1998 | 16 | 0.040 |
Why?
|
| Geography | 1 | 2018 | 17 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2018 | 112 | 0.030 |
Why?
|
| Calcium | 2 | 2010 | 361 | 0.030 |
Why?
|
| Community Health Centers | 3 | 1993 | 11 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 571 | 0.030 |
Why?
|
| Pacific Islands | 1 | 1995 | 2 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 1995 | 27 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1995 | 54 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1995 | 13 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 1 | 0.030 |
Why?
|
| Labor, Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 20 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 22 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 43 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 1994 | 18 | 0.030 |
Why?
|
| Fetal Death | 1 | 1993 | 4 | 0.030 |
Why?
|
| Demography | 2 | 2011 | 71 | 0.030 |
Why?
|
| Program Evaluation | 1 | 1994 | 116 | 0.030 |
Why?
|
| Medical Records | 1 | 1993 | 31 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 158 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 12 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2011 | 40 | 0.020 |
Why?
|
| Clostridium tetani | 1 | 2011 | 1 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2011 | 1 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2011 | 7 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 10 | 0.020 |
Why?
|
| Metronidazole | 1 | 2011 | 5 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 6 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 27 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 29 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 22 | 0.020 |
Why?
|
| Asia | 1 | 2009 | 9 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 332 | 0.020 |
Why?
|
| Bicarbonates | 1 | 2009 | 2 | 0.020 |
Why?
|
| Ferritins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 202 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2009 | 23 | 0.020 |
Why?
|
| Vaginal Smears | 3 | 1993 | 12 | 0.020 |
Why?
|
| Papanicolaou Test | 3 | 1993 | 9 | 0.020 |
Why?
|
| Ethics, Institutional | 1 | 1987 | 1 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 1987 | 2 | 0.020 |
Why?
|
| Government Regulation | 1 | 1987 | 2 | 0.020 |
Why?
|
| Federal Government | 1 | 1987 | 3 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 1987 | 20 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2006 | 2 | 0.020 |
Why?
|
| Transfer Agreement | 1 | 1986 | 1 | 0.020 |
Why?
|
| Patient Admission | 1 | 1986 | 21 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1333 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 2004 | 12 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2005 | 134 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 27 | 0.010 |
Why?
|
| Physical Examination | 2 | 1993 | 117 | 0.010 |
Why?
|
| Health Services | 1 | 1998 | 6 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 252 | 0.010 |
Why?
|
| Computers | 1 | 1976 | 17 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 1993 | 12 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 89 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 9 | 0.000 |
Why?
|
| Time | 1 | 1986 | 14 | 0.000 |
Why?
|